Jiangyin Tianjiang Pharmaceutical Co., Ltd. recruitment information, how about Jiangyin Tianjiang Pharmaceutical Co., Ltd.?

Data source: The following information comes from corporate credit reporting agencies. For more detailed corporate risk data, the company's official website and company profile, you can check it on DingTalk Enterprise Dian. For more company recruitment information, please consult the company's official website. .

Company profile:

Jiangyin Tianjiang Pharmaceutical Co., Ltd. was established on 1998-09-18, with a registered capital of 394.555556 million yuan, the legal representative is Yu Min, and the company address is Jiangyin No. 1, Xinsheng Road, High-tech Zone, the unified social credit code and tax number are 91320000703519845Q, the industry is manufacturing, the registration authority is Jiangsu Provincial Market Supervision Administration, and the business scope is the production of pharmaceuticals (operated according to the scope listed in the license); Production of beverages (solid beverages); testing of pharmaceutical raw materials and excipients; testing of traditional Chinese medicine formula particles; water and environmental testing; self-operated and agency import and export business of various commodities and technologies, but the state restricts the operation of enterprises or prohibits the import and export of commodities and technologies Except; production and sales of health food.

(Projects that require approval according to law can only carry out business activities after approval by relevant departments). The industrial and commercial registration number of Jiangyin Tianjiang Pharmaceutical Co., Ltd. is 320281000013451

Branch:

Jiangyin Tian Jiangyin Tianjiang Pharmaceutical Co., Ltd. Binjiang Development Zone Branch, the registration number is 320281000389460, and the unified social credit code is 91320000703519845Q

Jiangyin Tianjiang Pharmaceutical Co., Ltd. Shanghai Branch, the registration number is 310109000558501, the unified social credit code is 91320000703519845Q

External investment:

Heilongjiang Shuanglanxing Pharmaceutical Co., Ltd., the legal representative is Wang Longhu, the date of investment is 2007-10-22, the company status is in operation (opening), The registered capital is 8998.120000, and the investment ratio is 51.00

Sichuan Tianjiang Yifang Pharmaceutical Co., Ltd., the legal representative is Jiang Tao, the date of investment is 2017-11-22, the company status is in operation (opening), registered The capital is 10000.000000, and the investment ratio is 60.00

Yunnan Tianjiang Yifang Pharmaceutical Co., Ltd., the legal representative is Zhao Dongji, the date of investment is 2017-11-01, the company status is in operation (opening), and the registered capital It is 10000.000000, and the investment ratio is 60.00

Anhui Tianxiang Pharmaceutical Co., Ltd., the legal representative is Yu Min, the date of investment is 2010-12-20, the company status is in operation (opening), and the registered capital is 11000.000000, the investment ratio is 100.00

Jiangsu Jiangkang Pharmaceutical Co., Ltd., the legal representative is Yu Min, the date of investment is 2015-11-16, the company status is in operation (opening), and the registered capital is 7000.000000 , the capital contribution ratio is 51.00

Chongqing Tianjiang Pharmaceutical Co., Ltd., the legal representative is Jiang Tao, the capital contribution date is 2017-11-02, the company status is in operation (opening), and the registered capital is 6000.000000. The capital contribution ratio is 60.00

Sinopharm Group Zhonglian Pharmaceutical Co., Ltd., the legal representative is Xie Kongbiao, the date of capital contribution is 1998-04-09, the company status is in operation (opening), the registered capital is 62228.066100, capital contribution The ratio is 42.40

Liaoning Tianjiang Yifang Pharmaceutical Co., Ltd., the legal representative is Yu Min, the date of investment is 2019-01-30, the company status is in operation (opening), the registered capital is 15000.000000, the investment The ratio is 100.00

Heilongjiang Sinopharm Tianjiang Pharmaceutical Co., Ltd., the legal representative is Huang Zhangxin, the date of investment is 2017-07-28, the company status is in operation (opening), and the registered capital is 6000.000000. The investment ratio is 60.00

Fujian Chengtian Jinling Pharmaceutical Co., Ltd., the legal representative is Xu Yong, the date of investment is 2015-12-31, the company status is in operation (opening), and the registered capital is 13650.000000 , the investment ratio is 51.00

Sichuan Tianxiong Pharmaceutical Co., Ltd., the legal representative is Yu Min, the investment date is 2004-12-20, the company status is in operation (opening), and the registered capital is 7412.000000. The investment ratio is 51.00

Jiangyin Tianjiang Traditional Chinese Medicine Clinic Co., Ltd., the legal representative is Zhang Zhendong, the date of investment is 2011-11-03, the company status is in operation (opening), the registered capital is 1150.000000, and the investment The ratio is 51.00

Guangdong Yifang Pharmaceutical Co., Ltd., the legal representative is Cheng Xueren, the date of investment is 1993-02-10, the company status is in operation (opening), the registered capital is 36449.168000, and the investment ratio is 100.00

Shanghai Tianjiang Hengfeng Enterprise Management Consulting Co., Ltd., the legal representative is Zhou Jialin, the date of investment is 2011-12-20, the company status is canceled, and the registered capital is 10.

000000, the investment ratio is 100.00

Sichuan Sinopharm Tianjiang Pharmaceutical Co., Ltd., the legal representative is Huang Zhangxin, the date of investment is 2016-07-08, the company status is in operation (opening), the registered capital It is 15306.120000, and the capital contribution ratio is 51.00

Shareholder:

China Traditional Chinese Medicine Holdings Co., Ltd., the capital contribution ratio is 81.80, and the subscribed capital contribution is 32274.205600

Second in Guangdong Province Traditional Chinese Medicine (Guangdong Institute of Traditional Chinese Medicine Engineering and Technology), the capital contribution ratio is 12.70, and the subscribed capital contribution is 5011.530000

Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd., the capital contribution ratio is 5.50, and the subscribed capital contribution is 2169.820000

Senior management:

Zeng Xiaohui serves as a supervisor in the company

Wang Xiaochun serves as a director in the company

Yu Min serves as chairman and general manager of the company

Huang Zhangxin serves as a director of the company

Cheng Xueren serves as a director of the company

Huang He serves as a director of the company

Zhang Qingsheng serves as a director of the company Serving as a supervisor

Zhao Dongji serves as a director of the company

Liu Fajin serves as a director of the company